HealthTech firm Doctorlink has appointed Rupert Spiegelberg as its new CEO.
The firm, which provides access to digital symptom assessment to more than 10 million NHS patients across 1,350 GP practices, has made the new hire to take its success in the UK to new countries.
The firm, which has established US clients such as Kaiser Permanente and WebMD, also has a public private tele-health pilot launching in Europe early next year.
Speigelberg, a technology industry veteran, was most recently CEO of the Munich-based AI-powered digital identity company IDNow.
Prior, he was CEO of Investis Inc in New York, a global SaaS communications platform.
He succeeds former Doctorlink CEO and founder, Andrew Gardner, who will remain as a special advisor to the Board.
“Our success in the NHS has shown that Doctorlink’s platform is head and shoulders above the competition and we are excited to be rolling this technology out globally,” said Spiegelberg.
“The benefits in improving patient access to healthcare, shortening waiting times and helping NHS England to save costs makes it a very compelling proposition for primary healthcare providers and insurers.
“Our Symptom Assessment product has been proven to reduce the demand on NHS GPs by more than 20 per cent as well as take pressure off A&E departments. We now want to bring that transformation to patients and providers across the world.”
Doctorlink’s Symptom Assessment, developed over 18 years by a team of expert clinicians, is classified as a Class 1 Medical Equipment device by the Medicines and Healthcare products Regulatory Agency.
Doctorlink say its outcomes are sufficiently accurate to be fully indemnified, enabling the technology to be selected by the NHS.